Cetera Investment Advisers Phio Pharmaceuticals Corp. Transaction History

Cetera Investment Advisers

  • $44.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.64 - $2.35 $9,600 - $35,250
-15,000 Reduced 16.67%
75,000 $53,000
Q1 2022

May 13, 2022
BUY
$0.73 - $1.1 $36,500 - $55,000
50,000 Added 125.0%
90,000 $80,000
Q4 2021

Feb 14, 2022
BUY
$0.99 - $1.99 $9,900 - $19,900
10,000 Added 33.33%
40,000 $40,000
Q3 2021

Nov 16, 2021
BUY
$1.62 - $2.28 $48,600 - $68,400
30,000 New
30,000 $61,000

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Phio Pharmaceuticals Corp.

PHIO Quotes by TradingView
  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $25M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email